Management of Resistance to EGFR Tyrosine Kinase Inhibitors

被引：0
|
作者：
Mitsudomi, Tetsuya [1 ]
机构：
[1] Kindai Univ, Fac Med, Thorac Surg, Sayama, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Adenocarcinoma; EGFR; Resistance; T790M;
D O I：
10.1016/j.jtho.2016.11.073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SC04.02
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 50 条
  • [1] Mechanisms of resistance to EGFR tyrosine kinase inhibitors
    Lihua Huang
    Liwu Fu
    Acta Pharmaceutica Sinica B, 2015, 5 (05) : 390 - 401
  • [2] Mechanisms of resistance to EGFR tyrosine kinase inhibitors
    Huang, Lihua
    Fu, Liwu
    ACTA PHARMACEUTICA SINICA B, 2015, 5 (05) : 390 - 401
  • [3] EGFR Tyrosine Kinase Inhibitors: Difference in Efficacy and Resistance
    Kyle W. Robinson
    Alan B. Sandler
    Current Oncology Reports, 2013, 15 : 396 - 404
  • [4] EGFR Tyrosine Kinase Inhibitors: Difference in Efficacy and Resistance
    Robinson, Kyle W.
    Sandler, Alan B.
    CURRENT ONCOLOGY REPORTS, 2013, 15 (04) : 396 - 404
  • [5] EGFR tyrosine kinase inhibitors and multidrug resistance: perspectives
    Colabufo, Nicola A.
    Contino, Marialessandra
    Niso, Mauro
    Berardi, Francesco
    Leopoldo, Marcello
    Perrone, Roberto
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1811 - 1823
  • [6] Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors
    Luo, Min
    Fu, Li-Wu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (06): : 608 - 628
  • [7] Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors
    Giaccone, Giuseppe
    Wang, Yisong
    CANCER TREATMENT REVIEWS, 2011, 37 (06) : 456 - 464
  • [8] THE ROLE OF AXL IN ACQUIRED RESISTANCE TO EGFR TYROSINE KINASE INHIBITORS
    Lee, Jae Cheol
    Jang, Se Jin
    Choi, Chang-Min
    Kim, Kyu-Pyo
    Lee, Dae-Ho
    Kim, Sang-We
    Lee, Jung-Shin
    Kim, Woo Sung
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S678 - S678
  • [9] Characterization of Acquired Receptor Tyrosine Kinase Fusions as Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors
    Xu, H.
    Shu, Y.
    Jian, H.
    Shen, J.
    Xiang, J.
    Li, H.
    Li, B.
    Zhang, T.
    Zhang, L.
    Mao, X.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S562 - S563
  • [10] EGFR mutations and EGFR tyrosine kinase inhibitors
    Torri, Valter
    Broggini, Massimo
    Garassino, Marina Chiara
    LANCET ONCOLOGY, 2015, 16 (07): : 746 - 748
12345